← Patent-cliff monitor A biopharmaceutical company developing and commercializing products to treat central nervous system disorders
Company AngelList URL https://angel.co/vanda-pharmaceuticals CAGE Code 68U09 Legal Name Vanda Pharmaceuticals, Inc. Company Operating Status Active Crunchbase URL https://www.crunchbase.com/organization/vanda-pharmaceuticals Fax Number 202-296-1450 Full Address 2200 PENNSYLVANIA AVE NW STE 300E WASHINGTON, DC 20037 UNITED STATES LinkedIn URL https://www.linkedin.com/company/vanda-pharmaceuticals?trk=top_nav_home
27 upcoming patent cliffs Drug Ingredient Type Cliff
FANAPT ILOPERIDONE Small mol. Dec 2031 FANAPT ILOPERIDONE Small mol. Dec 2031 FANAPT ILOPERIDONE Small mol. Dec 2031 FANAPT ILOPERIDONE Small mol. Dec 2031 FANAPT ILOPERIDONE Small mol. Dec 2031 FANAPT ILOPERIDONE Small mol. Dec 2031 FANAPT ILOPERIDONE Small mol. Dec 2031 NEREUS TRADIPITANT Small mol. Aug 2036 HETLIOZ TASIMELTEON Small mol. Feb 2041 HETLIOZ LQ TASIMELTEON Small mol. Feb 2041 PONVORY PONESIMOD Small mol. Oct 2042 PONVORY PONESIMOD Small mol. Oct 2042 PONVORY PONESIMOD Small mol. Oct 2042 PONVORY PONESIMOD Small mol. Oct 2042 PONVORY PONESIMOD Small mol. Oct 2042 PONVORY PONESIMOD Small mol. Oct 2042 PONVORY PONESIMOD Small mol. Oct 2042 PONVORY PONESIMOD Small mol. Oct 2042 PONVORY PONESIMOD Small mol. Oct 2042 PONVORY PONESIMOD Small mol. Oct 2042 BYSANTI MILSAPERIDONE Small mol. May 2044 BYSANTI MILSAPERIDONE Small mol. May 2044 BYSANTI MILSAPERIDONE Small mol. May 2044 BYSANTI MILSAPERIDONE Small mol. May 2044 BYSANTI MILSAPERIDONE Small mol. May 2044 BYSANTI MILSAPERIDONE Small mol. May 2044 BYSANTI MILSAPERIDONE Small mol. May 2044 Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.